Caution:At present, there are occasional discrepancies in the display of intellectual property rights holders and their representatives. We are working on a solution.
see.ip - Details for KRISTALLINE FORM VON 1-(1-METHYL-1H-PYRAZOL-4-YL)-N-((1R,5S,7S)-9-METHYL-3-OXA-9-AZABICYCLO[3.3.1]NONAN-7-YL)-1H-INDOL-3-CARBOXAMID
Details for 2015778162
Up to date per 13.06.2026
Actions
Details for 2015778162
Title / Product Name
KRISTALLINE FORM VON 1-(1-METHYL-1H-PYRAZOL-4-YL)-N-((1R,5S,7S)-9-METHYL-3-OXA-9-AZABICYCLO[3.3.1]NONAN-7-YL)-1H-INDOL-3-CARBOXAMID
Status
Granted/Registered
Protection Type
European Patent
(AT-) Application Number
2015778162
EP Publication Number
3201203
E-Number
1393865
Language
EN
PCT Number
US15052806
Publication Date
09.08.2017 A
19.05.2021 B1
Registration Date
19.05.2021
AT Publication Date
15.06.2021
Application Date
29.09.2015
Registration Number
-
Priorities
29.09.2014
US
201462056982 P
IPC
C07D 498/08 20060101AFI20160415BHEP
Maximum Duration of Protection
29.09.2035
Owner
Takeda Pharmaceutical Company Limited1-1 Doshomachi 4-chome Chuo-ku Osaka-shi, Osaka 541-0045JP
Representative
No representatives present
Inventor
ZHAO, Yuxinc/o Takeda California Inc. 10410 Science Center Drive San Diego, California 92121US